LINC00963 promotes NSCLC metastasis by interacting with the glycolytic kinase PGK1 and preventing its ubiquitination, leading to activation of the oncogenic AKT/mTOR signaling pathway20. Here, AKT1 is linked to non-small cell lung carcinoma.